Akoya Biosciences Inc - ESG Rating & Company Profile powered by AI
Jump to the end of the page for potential risks for Akoya Biosciences Inc based on industry, geography and marketcap. This webpage is a zero-cost Sustainability report for Akoya Biosciences Inc. Complete ESG assessment of Akoya Biosciences Inc are accessed by signing in.
Akoya Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.9; made up of an environmental score of 6.7, social score of 6.9 and governance score of 6.0.
6.9
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 355 | Xbrane Biopharma AB | 7.0 | High |
| 355 | Xenetic Biosciences Inc | 7.0 | High |
| 387 | Akoya Biosciences Inc | 6.9 | High |
| 387 | Advanced Medical Solutions Group PLC | 6.9 | High |
| 387 | Acrux Ltd | 6.9 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Akoya Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Akoya Biosciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Akoya Biosciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Akoya Biosciences Inc offer flexible work?
Sign up for free to unlockDoes Akoya Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Akoya Biosciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Akoya Biosciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose water use targets?
Sign up for free to unlockDoes Akoya Biosciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Akoya Biosciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Akoya Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Akoya Biosciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Akoya Biosciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Akoya Biosciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Akoya Biosciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose its waste policy?
Sign up for free to unlockDoes Akoya Biosciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose energy use targets?
Sign up for free to unlockDoes Akoya Biosciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Akoya Biosciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Akoya Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.